Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
Authors
Keywords
Atrial fibrillation, Epicardial adipose tissue, Angiotensin, Renin angiotensin system inhibitors
Journal
HEART FAILURE REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-02
DOI
10.1007/s10741-019-09837-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Renin–angiotensin–aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy
- (2018) Chen-Yu Huang et al. HEART
- Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation
- (2018) Xuewen Wang et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Pitcher perfect: arrhythmia monitoring at the Munich Oktoberfest
- (2017) Jorge A. Wong et al. EUROPEAN HEART JOURNAL
- Modulation of RAAS-natriuretic peptides in the treatment of HF: Old guys and newcomers
- (2017) Vincenzo Mollace et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure
- (2017) Francesco Rossi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases
- (2017) A Mascolo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE
- (2016) Franz Duca et al. Circulation-Cardiovascular Imaging
- Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis
- (2016) Sandip Chaugai et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- ACE2/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity
- (2016) Vaibhav B. Patel et al. Adipocyte
- Human monocyte subsets exhibit divergent angiotensin I-converting activity
- (2015) M. Rutkowska-Zapała et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Novel RAAS agonists and antagonists: clinical applications and controversies
- (2015) Cesar A. Romero et al. Nature Reviews Endocrinology
- Epicardial adipose tissue and atrial fibrillation
- (2014) S. N. Hatem et al. CARDIOVASCULAR RESEARCH
- Left Atrium in Heart Failure With Preserved Ejection Fraction
- (2014) Andrea Rossi et al. Circulation-Heart Failure
- Angiotensin-(1-12): A Chymase-Mediated Cellular Angiotensin II Substrate
- (2014) Sarfaraz Ahmad et al. CURRENT HYPERTENSION REPORTS
- Epicardial adipose tissue-based defragmentation approach to persistent atrial fibrillation: Its impact on complex fractionated electrograms and ablation outcome
- (2014) Shiro Nakahara et al. HEART RHYTHM
- Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
- (2014) Un Jung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of atrial fibrillation: European perspective
- (2014) Massimo Zoni-Berisso et al. Clinical Epidemiology
- Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines
- (2013) Nicolas Venteclef et al. EUROPEAN HEART JOURNAL
- The renin–angiotensin system in adipose tissue and its metabolic consequences during obesity
- (2013) Maria E. Frigolet et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Does Location of Epicardial Adipose Tissue Correspond to Endocardial High Dominant Frequency or Complex Fractionated Atrial Electrogram Sites During Atrial Fibrillation?
- (2012) Koichi Nagashima et al. Circulation-Arrhythmia and Electrophysiology
- Angiotensin II AT1receptor blockers as treatments for inflammatory brain disorders
- (2012) Juan M. Saavedra CLINICAL SCIENCE
- Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery*
- (2012) Mias Pretorius et al. CRITICAL CARE MEDICINE
- Role of inflammation in early atrial fibrillation recurrence
- (2012) M. D. Smit et al. EUROPACE
- 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design
- (2012) Hugh Calkins et al. HEART RHYTHM
- Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials
- (2012) Rasha Khatib et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies
- (2012) Paolo Verdecchia et al. JOURNAL OF HYPERTENSION
- A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients
- (2012) Domenico Galzerano et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Treatment of Long-Lasting Persistent Atrial Fibrillation Using Minimally Invasive Surgery Combined With Irbesartan
- (2011) Jian-Gang Wang et al. ANNALS OF THORACIC SURGERY
- Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis
- (2011) Suguru Yamamoto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: Insights from the Canadian Trial of Atrial Fibrillation (CTAF)
- (2011) Maryse Palardy et al. CANADIAN JOURNAL OF CARDIOLOGY
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter
- (2011) Atul Verma et al. CANADIAN JOURNAL OF CARDIOLOGY
- Systematic Review and Meta-Analysis: Renin-Angiotensin System Inhibitors in the Prevention of Atrial Fibrillation Recurrences. An Unfulfilled Hope
- (2011) Marcello Disertori et al. CARDIOVASCULAR DRUGS AND THERAPY
- Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial
- (2011) Andreas Goette et al. Circulation-Arrhythmia and Electrophysiology
- Effect of Telmisartan and Ramipril on Atrial Fibrillation Recurrence and Severity in Hypertensive Patients With Metabolic Syndrome and Recurrent Symptomatic Paroxysmal and Persistent Atrial Fibrillation
- (2011) Roberto Fogari et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages
- (2011) Laura L. Souza et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Irbesartan in Patients with Atrial Fibrillation
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor
- (2011) Hui Yang et al. PEPTIDES
- Renin, (pro)renin and receptor: an update
- (2010) Genevieve Nguyen CLINICAL SCIENCE
- Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study)
- (2010) T. Yamashita et al. EUROPACE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery
- (2010) Antonios Kourliouros et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Role of adipose tissue renin–angiotensin system in metabolic and inflammatory diseases associated with obesity
- (2010) Laurent Yvan-Charvet et al. KIDNEY INTERNATIONAL
- Angiotensin-(1–7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs
- (2010) Enzhao Liu et al. REGULATORY PEPTIDES
- Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
- (2009) Riccardo Cappato et al. Circulation-Arrhythmia and Electrophysiology
- Role of renin–angiotensin system in adipose tissue dysfunction
- (2009) Masaru Iwai et al. HYPERTENSION RESEARCH
- Enalapril, irbesartan, and angiotensin-(1–7) prevent atrial tachycardia-induced ionic remodeling
- (2009) Enzhao Liu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
- (2009) Roland E Schmieder et al. JOURNAL OF HYPERTENSION
- Valsartan for Prevention of Recurrent Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Valsartan and Ramipril on Atrial Fibrillation Recurrence and P-wave dispersion in Hypertensive Patients With Recurrent Symptomatic Lone Atrial Fibrillation
- (2008) R. Fogari et al. AMERICAN JOURNAL OF HYPERTENSION
- The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS
- (2008) Giuseppina Novo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation
- (2008) A. Ringborg et al. EUROPACE
- Prevention of Recurrent Lone Atrial Fibrillation by the Angiotensin-II Converting Enzyme Inhibitor Ramipril in Normotensive Patients
- (2008) Fabio Belluzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of the renin–angiotensin system in vascular inflammation
- (2008) Chiara Marchesi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now